Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02595866 |
|---|---|
| Brief Title: | Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms |
| First Submitted : | November 3, 2015 |
| First Submitted that Met QC Criteria : | November 3, 2015 |
| First Posted : | November 4, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 7, 2021 |
| Last Update Posted : | January 8, 2021 |